Evidence suggests that the gut-brain axis can influence stress-related behaviour, mood and neuropsychological disorders, including anxiety. Stress exposure can increase anxiety-related symptoms such as muscle tension & worrying. Medical treatment has low success and a range of side effects on anxiety. This review aimed to see if probiotics can reduce anxiety symptoms in humans. Where relevant articles on people with anxiety disorders are lacking, the review evaluates articles addressing healthy participants in stressful situations such as exams or public speeches via anxiety questionnaires. I hypothesized that probiotics could be an effective anxiolytic treatment in combination with therapy. Most articles demonstrated reduced subjective and objective results in anxiety and stress measurements after a daily intake of probioticstrains. Findings demonstrate potential anxiolytic benefits with a daily probiotic intake. However, future research on participants with an anxiety disorder is needed to conclude the hypothesis.

This study aimed to isolate and characterize in-vitro and under simulated colonic conditions, probiotic candidates isolated from food environment producing γ-aminobutyric acid (GABA), a major inhibitory neuromediator of the enteric nervous system with a potential role in modulating the immune system in many health disorders. Several lactic acid bacteria were isolated and detected for the presence of the gadB gene using PCR and GAD enzymatic assay. The most active strains with high and fast production kinetics were identified, characterized, and included Streptococcus thermophilus, Lactiplantibacillus plantarum, and Lactobacillus delbrueckii subsp. bulgaricus. The biological safety (i.e., sensitivity to antibiotics and the presence of virulence factors) and probiotic potential (i.e., resistance to gastrointestinal conditions and whole-genome sequencing) of identified bioactive strains was also confirmed in vitro. The growth, GABA production, and competitiveness of selected probiotic candidates (B. animalis, S. thermophilus, and L. bulgaricus) were investigated in the presence of human gut microbiota ex vivo in a model of a proximal colon mimicking physiological and microbiological conditions of the human large intestine. Supplementation with GABA-producing probiotic candidates did not affect the overall gut microbiota diversity over 48 h of treatment. However, we observed modulation of the microbiome composition, especially change of Bacteroides population, a key gut microbe associated with anti-depressive and anti-inflammatory activities. The level of microbiota-generated butyrate within 12 h of treatment was significantly increased compared to control. Results from this study demonstrated the probiotic potential of tested GABA-producing bacteria and their impact on gut microbiota structure and metabolism, suggesting their suitability for gut health-promoting application.

Toll-like receptor (TLR) ligands and phytochemical feed additives (PFAs) were evaluated in this study to determine the effects of immune stimulation on gut immunity in the zebrafish, Danio rerio, and the channel catfish, Ictalurus punctatus. Rag1-/- (MT) zebrafish were used to study how the TLR ligands β-glucan and resiquimod (R848) affect the innate immune system in the gut of MT zebrafish. Enhanced expression of marker genes (NITR9, NCCRP-1 and MPEG-1) indicated stimulation of Natural Killer (NK) cells, non-specific cytotoxic cells (NCCs) and macrophages. After challenge with Edwardsiella ictaluri, MT zebrafish stimulated with β-glucan demonstrated higher survival and the presence of more macrophages/monocytes in the gut than control MT zebrafish. A PFA test diet containing a blend of prebiotic fiber, oregano, thyme, cinnamon essential oils, and Yucca schidigera (ONE Current™, OC) was fed to channel catfish for 3 months in ponds to determine the effect on channel catfish fingerling growth. Fish were fed in ponds and a tank bacterial challenge followed to test the efficacy of the product. Catfish fed OC demonstrated greater weight gain and feed conversion ratios, higher survival after challenge with E. ictaluri, greater phagocytosis or binding by macrophages and cytotoxic cells. Catfish fed OC also demonstrated greater gut surface area after 2 months feeding OC. To elucidate the effect(s) of each of the compounds in the OC diet on gut immune responses and to determine if PFAs can decrease bacterial colonization and replication within gut tissues, WT and MT zebrafish were fed diets containing different compounds included in OC. Quantification of live bacteria from gut and kidney tissue was determined after challenge with E. ictaluri. Expression levels of immune response genes were evaluated after ingestion of PFAs. Actifibe, Essential oil 25 ppm (EO 25) and Actifibe + EO demonstrated the lowest infection and colonization rate, upregulation of immune response genes, and significantly higher survival when challenged with E. ictaluri. This study demonstrates the potential for application of TLR ligand and feed administered PFAs to improve fish health. Our findings provide a more comprehensive understanding of host gut/pathogen interactions as well as suggestions for novel disease control measures.

京都大学 / 新制・課程博士 / 博士(理学) / 甲第24184号 / 理博第4875号 / 新制||理||1698(附属図書館) / 京都大学大学院理学研究科生物科学専攻 / (主査)准教授 半谷 吾郎, 准教授 Huffman Michael Alan, 教授 今井 啓雄 / 学位規則第4条第1項該当 / Doctor of Science / Kyoto University / DGAM

It is well known that the elderly often manifest chronic low-grade inflammation. This phenomenon, called “inflamm-aging,” is postulated to contribute to increased susceptibility towards infectious diseases and an overall increase in frailty. We have proposed examining the gut microbiome as a potential mediator of these changes. Gut microbial communities influence the host immune system; often dictating an individual’s health status. Thus, harmful gut microbiome changes, termed dysbiosis, are associated with poor health in the elderly. We first sought to understand the key immunological, physiological and microbiome changes occurring with age (Chapter 3). Our data reveals immune impairments in aged mice, with increased intestinal permeability, systemic inflammation and alterations in the functions of myeloid cell populations. However, our aged germ-free (GF) mice are protected from these outcomes, indicating that the old microbiome may play a strong role in these age-associated impairments. To study this further, we have colonized young and old GF mice with the “young” or “old” microbiota in order to determine whether the relationship between microbial dysbiosis with age and health status is correlative or causative (Chapter 4). Interestingly, young GF mice colonized with old microbiota have significantly increased permeability, systemic inflammation and an influx of Ly6Chigh monocytes when compared to those colonized with the young microbiota. By using transgenic mice (TNF-/- mice), or by reducing systemic TNF levels via therapeutics, we were able to reduce some aspects of microbial dysbiosis and age-associated inflammation (Chapter 5). Our data suggests that harmful changes to the gut microbiome composition with age initiate a cycle of negative events that ultimately result in increased inflammatory myeloid cell recruitment, increased intestinal permeability and an overall increase in systemic inflammation in old mice. By identifying these key changes, we can work towards developing effective therapeutics that promotes healthy aging and protection against infectious diseases. / Thesis / Master of Science (MSc) / Élie Metchnikoff first coined the term “dysbiosis” when he described the imbalance in microbial populations that could result anywhere in the body. Since then, numerous studies have examined the role of the intestinal microbiota in defense against pathogens. Metchnikoff also suggested that the gut composition and function is altered with age and this can in turn; increase the host’s susceptibility towards infectious diseases. My research aims to characterize the role of microbial dysbiosis on the immune defects with age. To do so, I will be utilizing a unique set of mice, called gnotobiotic mice. These mice are housed under specific germ-free conditions and contain no microbiome. Thus, they provide us with the ideal model to study the effects of the microbiome on immune function. The findings from these studies will help in the development of preventative and therapeutic alternatives to provide the elderly with more years of healthy, independent living.

Systemic Lupus Erythematosus (SLE) stands as a multifaceted autoimmune disorder, characterized by a spectrum of clinical manifestations and the generation of autoantibodies against self-antigens. Our focus was on the pivotal role of B cells in the development of SLE. The study also underscored the significant contribution of regulatory B (Breg) cells in the context of SLE, suggesting their potential as key regulators of the disease process. Our results provided a deeper understanding of the intricate interplay between B cells and SLE, offering insights that were valuable for both scientific research and future designs of therapeutic approaches. Cutting-edge single-cell RNA sequencing was employed to analyze the differences in splenic Breg subsets and their molecular profiles across different stages of lupus development in mice. Transcriptome-based changes in Bregs during active disease were confirmed through phenotypic analysis. These findings provided crucial insights into the dynamic role of B cells in the pathogenesis of SLE. In addition, we delved into the intricate connection between SLE and the gut microbiota. A literature review offered a comprehensive analysis of current research, with a particular emphasis on potential interactions between bacterial flagellin and Toll-Like Receptor 5 (TLR5) on immune cells. These interactions garnered substantial attention due to their potential implications in the pathogenesis of SLE. We synthesized existing research, providing valuable insights into the complex interplay between SLE and the microbiota and suggesting promising avenues for further investigation and potential therapeutic interventions. In the final study, we explored lupus-like disease in mice with global Tlr5 deletion, initially expecting disease attenuation. Surprisingly, the results revealed an exacerbation of lupus-like symptoms, particularly in female mice lacking Tlr5. Future research will seek to uncover the mechanisms by which Tlr5 deletion modulates interactions between the host and the gut microbiota, ultimately contributing to the exacerbation of lupus-like disease. / Doctor of Philosophy / Systemic Lupus Erythematosus (SLE) is characterized by a range of health issues and the body attacking itself. In this exploration, we journey through the intricate landscape of SLE, uncovering key players and unexpected twists. In this dissertation, we journeyed through the intricate landscape of SLE, uncovering key players and unexpected twists. In this dissertation, we closely examined these immune cells, revealing how different types of B cells contributed to SLE's development. We also introduced the enigmatic regulatory B (Breg) cells, which acted as potential peacekeepers in this autoimmune reaction. Our results illuminated the complex relationship between B cells and SLE, offering insights that benefited both researchers and those seeking new treatments. We employed cutting-edge technology, single-cell RNA sequencing, to scrutinize the genetic fingerprints of B cells in mice with SLE. The results unveiled changes in Breg cells during active disease, providing critical clues about how B cells impacted SLE progression. In addition, this dissertation took us into the microscopic world of our gut inhabitants, the microbiota. We dived into a treasure trove of research, focusing on how interactions between bacterial flagellin and various microbiota elements affected immune cells through a special receptor called Toll-Like Receptor 5 (TLR5). These interactions, like hidden clues, had piqued scientists' interest for their potential role in SLE development. We synthesized existing research, offering valuable insights into the complex interplay between SLE and our microbiota. The discussion also suggested promising paths for future research and potential therapies. In the final study, we encountered a plot twist. We anticipated that deleting the Tlr5 gene would improve lupus-like disease in mice. To our surprise, the opposite happened. Lupus-like symptoms worsened, especially in female mice lacking Tlr5. Clinical signs included enlarged spleens and lymph nodes, increased immune cell activity, and kidney inflammation. But Tlr5 deletion didn't change the mice's metabolism or the leaky gut. Instead, it reshaped their gut's microbial residents. Future research aimed to uncover how Tlr5 deletion altered the interactions between the host and gut microbes, ultimately making lupus-like disease more severe. In a nutshell, this journey through SLE's complex world provided a deeper understanding of its intricacies. We met the B cells, explored the microbiota, and encountered surprises along the way. These discoveries were vital pieces of the puzzle, bringing us closer to unlocking the secrets of SLE and, perhaps, finding new ways to manage and treat this challenging autoimmune disorder.

Temperature represents a major driving force in biology as it influences essential functions across multiple levels of biological organization. The role of temperature is especially important for ectothermic animals, whose biotic processes are dependent on both body and environmental temperature. Assessing the relationship between temperature and organismal performance represents an important research direction as temperatures continue to warm under anthropogenic climate change. Chapters two and three are focused on a recently colonized population of the invasive Mediterranean House Geckos at the northern edge of their invasion front. These chapters examine the ecological and physiological factors that enable these lizards to persist in a cooler and more temperate environment than their native range. The thermal breadth of a reptile greatly influences its ability to tolerate a thermally variable environment, particularly when environmental options are limited for behavioral thermoregulation. These chapters explore the thermal performance of this species, and the results show that the eurythermality of these geckos promotes their rapid colonization of novel environments despite experiencing prolonged periods of cool temperatures. Chapters four, five, and six, by contrast, shift focus to larval amphibians to explore the constraints and factors underlying plasticity in acclimation to temperature extremes. As habitats continue to warm with climate change, ectotherms with limited capacity to thermoregulate, such as larval amphibians in shallow ponds, will be under a heightened threat of heat stress and mortality. Resultantly, identifying different factors that can increase organismal heat tolerance would reduce the risk of overheating and promote survival. Chapters four, five, and six explore this topic by measuring the critical thermal maximum (CTmax) of larval wood frogs. Chapter four focuses on the tradeoff between basal CTmax and plasticity of CTmax and its consequences for how a larval anuran responds to an acute heat shock. Chapter five examines the role a viral pathogen, ranavirus, has on larval CTmax. Surprisingly, a lethal dose of ranavirus did not reduce CTmax which goes against the common pattern of pathogenic infections lowering host heat tolerance. Lastly, chapter six explores the relationship between the gut microbiota and host CTmax with a particular focus on cross-species microbiota transplants. In line with our prediction, transplanting the gut microbiota of a heat-tolerant donor species promoted greater CTmax in the heat-sensitive recipient species.

Plant-based proteins have gained popularity because of their high nutritional value and more sustainable alternative to animal-based proteins. Soybean and chickpea are two widely consumed plant-based proteins, whereas tempeh is a popular plant-based fermented whole food product that is rich in protein. With the increase in the development of plant-based food products, there is little research into how plant proteins affect gut microbiota characteristics and metabolites. Therefore, there is a need to understand the underlying mechanisms surrounding the consumption of these foods. The purpose of this study was to investigate the health benefits of soybean, chickpea, and their tempeh counterparts’ consumption as whole foods on the gut microbiota and metabolites. Our results showed that soybean tempeh significantly increased the abundance of beneficial probiotic bacteria such as Roseburia and Ruminiclostridium 5 in the gut microbiota of mice. Additionally, soybean tempeh and soybean significantly increased Muribaculaeceae abundance, known to increase SCFA production in the colon. Lachnospiraceae NKA136 was significantly increased in soybean tempeh, soybean, and chickpea groups which may allow these foods to be used as a way of probiotic restoration. Our results showed that all dietary supplementation groups had significantly altered metabolic profiles compared to the control group. The soybean tempeh group had higher levels of peroxide (vitamin B6), myoinositol, and tetrahydrobiopterin while the chickpea tempeh group had higher levels of metabolites such as 3 hydroxyanthranilic acid. The soybean group had higher levels of metabolites such as 3-hydroxytryptophan (Oxitriptan) whereas the chickpea protein group had higher levels of metabolites such as 3-hydroxyanthranilic acid and oxitriptan. In conclusion, our study suggests that different plant-based foods can have distinct effects on gut microbiota and metabolic profiles in mice. These findings may have implications for human health and warrant further investigation into the effects of plant protein consumption on human metabolism.

Huntington disease (HD) is an inherited neurodegenerative disease caused by a trinucleotide repeat expansion in the huntingtin (HTT) gene. Metabolic dysfunction is a feature of HD that is recapitulated in HD mouse models. Our lab has shown that circadian feeding rhythms are disrupted in humanized HD mice and restored by suppression of brain HTT. Furthermore, when circadian feeding rhythm is artificially restored, in addition to normalization of metabolic function, liver and striatal HTT is temporarily reduced, demonstrating that HTT is involved in gut-brain feedback. The gut microbiome, which can regulate gut-brain feedback, has been implicated in the pathogenesis of other central nervous system disorders and we hypothesize it also plays a role in HD. The objective of this study is to investigate alterations in relative abundance of HD gut microbiota using existing plasma metabolomics data to identify candidate bacteria. If distinct microbiota profiles are demonstrated, this would provide the basis for future unbiased studies to investigate the complete HD microbiome.

No description available.